Outlook Therapeutics (OTLK) Depreciation and Depletion (2019 - 2022)
Outlook Therapeutics (OTLK) reported Depreciation and Depletion of $40906.0 for Q3 2022, little changed year-over-year from $40906.0 in Q3 2021, and little changed quarter-over-quarter from $40906.0 in Q2 2022.
Outlook Therapeutics (OTLK) Depreciation and Depletion (2019 - 2022) Analysis & Trends
Outlook Therapeutics (OTLK) has 4 years of Depreciation and Depletion data on file, last reported at $40906.0 in Q3 2022.
- Depreciation and Depletion for Q3 2022 came in at $40906.0, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2022 was $163625.0 (changed 0.0% YoY), and the FY2022 annual result was $163625.0, changed 0.0% from the prior year.
- Depreciation and Depletion was little changed at $40906.0 in Q3 2022 per OTLK's latest filing, from $40906.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $63776.0 in Q4 2019 and troughed at $40906.0 in Q3 2020.
- A 4-year average of $45555.4 and a median of $40906.0 in 2020 frame the typical range for Depreciation and Depletion.
- The sharpest annual moves came in 2020 and 2021: Depreciation and Depletion plunged 35.86% in 2020, then grew 0.0% in 2021.
- A 4-year view of Depreciation and Depletion shows it stood at $63776.0 in 2019, then sank by 35.86% to $40906.0 in 2020, then gained by 0.0% to $40907.0 in 2021, then fell by 0.0% to $40906.0 in 2022.
- Business Quant data shows OTLK's Depreciation and Depletion at $40906.0 in Q3 2022, $40906.0 in Q2 2022, and $40906.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Outlook Therapeutics | 51.56 Mn | 43.81 Mn | -21,888.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 40,906.00 |
| Sep 30, 2022 | 40,906.00 |
| Jun 30, 2022 | 40,906.00 |
| Jun 30, 2022 | 40,906.00 |
| Mar 31, 2022 | 40,906.00 |
| Mar 31, 2022 | 40,906.00 |
| Dec 31, 2021 | 40,907.00 |
| Dec 31, 2021 | 40,907.00 |
| Sep 30, 2021 | 40,906.00 |
| Sep 30, 2021 | 40,906.00 |
| Jun 30, 2021 | 40,906.00 |
| Jun 30, 2021 | 40,906.00 |
| Mar 31, 2021 | 40,906.00 |
| Mar 31, 2021 | 40,906.00 |
| Dec 31, 2020 | 40,906.00 |
| Dec 31, 2020 | 40,906.00 |
| Sep 30, 2020 | 40,906.00 |
| Sep 30, 2020 | 40,906.00 |
| Jun 30, 2020 | 50,959.00 |
| Jun 30, 2020 | 50,959.00 |